The decision comes after a paper published in The Lancet found using the drug to treat coronavirus led to higher rates of death and heart issues.
hydroxychloroquine as a coronavirus treatment, saying earlier this month “what do you have to lose?” by taking the drug.Use of the drug to treat coronavirus first came to prominence in March, after a small trial from a French doctor showed that the drug may have had some positive effect in treating coronavirus. Despitefrom much of the medical community, a rush for the drug then ensued around the world, leading to shortages.
Questions continued regarding its effectiveness, though, with the recent paper — taking results from over 96,000 patients in 671 hospitals — perhaps the most comprehensive look yet. “The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board,” Ghebreyesus said, adding that “the other arms of the trial are continuing.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
WHO pauses trial of hydroxychloroquine as coronavirus treatment amid safety concernsHydroxychloroquine, which Trump has repeatedly touted as a potential game changer in fighting the coronavirus, is an anti-malarial drug that's also used by doctors to treat rheumatoid arthritis and lupus.
Weiterlesen »
WHO pauses hydroxychloroquine trial amid safety concerns day after Trump says he stopped taking controversial medicineThe trial pause comes the day after the president revealed he was no longer taking the unproven coronavirus treatment and prevention method that health experts and officials—including within the Trump administration—have warned not to use.
Weiterlesen »
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concernsThe World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
Weiterlesen »
WHO temporarily pauses studying hydroxychloroquine due to safety concernsThe coronavirus pandemic has brought countries to a standstill. Here's the latest updates on Covid-19 cases, deaths, government responses and more.
Weiterlesen »
WHO temporarily halts trial of hydroxychloroquine over safety concernsThe group wants to 'be proactive, err on the side of caution' when it comes to the malaria drug's use in treating COVID-19.
Weiterlesen »
WHO temporarily halts trial of hydroxychloroquine over safety concernsThe World Health Organization announced on Monday that it's suspending a trial of hydroxychloroquine in treating COVID-19, saying fears of the drug's potential danger is causing it to 'err on the side of caution'
Weiterlesen »